227 related articles for article (PubMed ID: 12598373)
1. Biologic therapies for juvenile arthritis.
Wilkinson N; Jackson G; Gardner-Medwin J
Arch Dis Child; 2003 Mar; 88(3):186-91. PubMed ID: 12598373
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review.
Shenoi S; Wallace CA
Paediatr Drugs; 2010 Dec; 12(6):367-77. PubMed ID: 21028916
[TBL] [Abstract][Full Text] [Related]
3. Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.
Carrasco R; Smith JA; Lovell D
Paediatr Drugs; 2004; 6(3):137-46. PubMed ID: 15170361
[TBL] [Abstract][Full Text] [Related]
4. [New drugs and treatment strategies for rheumatoid arthritis].
Fantini F
Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
[TBL] [Abstract][Full Text] [Related]
5. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study.
Lahdenne P; Vähäsalo P; Honkanen V
Ann Rheum Dis; 2003 Mar; 62(3):245-7. PubMed ID: 12594111
[TBL] [Abstract][Full Text] [Related]
6. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
7. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
Tobin AM; Kirby B
BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
[TBL] [Abstract][Full Text] [Related]
8. [Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience].
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Reumatismo; 2007; 59(3):244-61. PubMed ID: 17898886
[TBL] [Abstract][Full Text] [Related]
9. Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis.
Nerome Y; Imanaka H; Nonaka Y; Takei S
Mod Rheumatol; 2007; 17(6):526-8. PubMed ID: 18084710
[TBL] [Abstract][Full Text] [Related]
10. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis.
Tynjälä P; Lindahl P; Honkanen V; Lahdenne P; Kotaniemi K
Ann Rheum Dis; 2007 Apr; 66(4):548-50. PubMed ID: 17068061
[TBL] [Abstract][Full Text] [Related]
11. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
[TBL] [Abstract][Full Text] [Related]
12. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P
Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
[No Abstract] [Full Text] [Related]
13. Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.
Inanc N; Direskeneli H
Rheumatol Int; 2006 Nov; 27(1):67-71. PubMed ID: 16896990
[TBL] [Abstract][Full Text] [Related]
14. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.
Tynjälä P; Lahdenne P; Vähäsalo P; Kautiainen H; Honkanen V
Ann Rheum Dis; 2006 Aug; 65(8):1044-9. PubMed ID: 16449314
[TBL] [Abstract][Full Text] [Related]
15. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
Koike R; Takeuchi T; Eguchi K; Miyasaka N;
Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
[TBL] [Abstract][Full Text] [Related]
16. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
17. Biologic therapy for psoriasis--the first wave: infliximab, etanercept, efalizumab, and alefacept.
Weinberg JM; Saini R; Tutrone WD
J Drugs Dermatol; 2002 Dec; 1(3):303-10. PubMed ID: 12851990
[TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis to etanercept in two children with juvenile idiopathic arthritis.
Crayne CB; Gerhold K; Cron RQ
J Clin Rheumatol; 2013 Apr; 19(3):129-31. PubMed ID: 23519173
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab.
Tarkiainen M; Tynjälä P; Vähäsalo P; Lahdenne P
Scand J Rheumatol; 2011 Mar; 40(2):150-2. PubMed ID: 20868307
[No Abstract] [Full Text] [Related]
20. Etanercept and infliximab for rheumatoid arthritis.
Drug Ther Bull; 2001 Jul; 39(7):49-52. PubMed ID: 11471515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
